News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onyx Pharmaceuticals, Inc. (ONXX) Rejects Amgen (AMGN)'s $10 Billion Offer, Looking for Suitor


7/1/2013 5:59:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Onyx Pharmaceuticals Inc. (ONXX), the maker of the cancer drug Nexavar, said it is in contact with other possible acquirers after rejecting an unsolicited $120-a-share cash takeover bid from Amgen Inc. (AMGN)

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters
Read at New York Times
Read at Boston Globe
Read at Los Angeles Times
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES